Gastric bypass may raise risk of kidney stones

June 30, 2009 — NEW YORK (Reuters Health) - The risk of kidney stone disease and kidney stone surgery is increased following gastric bypass surgery that is performed to treat morbid obesity, according to a study published in the Journal of Urology.

NSAIDs may interfere with prostate cancer diagnosis

June 23, 2009 — NEW YORK (Reuters Health) - Frequently used, over-the-counter drugs referred to as "nonsteroidal anti-inflammatory drug," (NSAIDs), such as aspirin, ibuprofen and others, may interfere with the early diagnosis of prostate cancer, according to Tennessee-based researchers.

Agent Orange worsens prostate cancer prognosis

May 1, 2009 — NEW YORK (Reuters Health) - Among Vietnam veterans who have undergone major prostate cancer surgery, those who were exposed to Agent Orange have an increased risk of an aggressive recurrence, according to results of a study appearing in the British Journal of Urology (BJU) International.

Survival extended by Dendreon cancer vaccine

April 28, 2009 — NEW YORK (Reuters) - An experimental cancer vaccine developed by Dendreon Corp improved three-year survival of patients with advanced prostate cancer by 38 percent compared with a placebo, according to data from a closely watched study unveiled on Tuesday.

Group recommends baseline prostate testing at 40

April 27, 2009 — CHICAGO (Reuters) - A U.S. physicians' group is recommending that men 40 and older be offered a controversial prostate cancer test, adding to confusion over whether younger men should get the screening test.